These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 8229498)
1. A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis. Ashkenazi S; Amir J; Waisman Y; Rachmel A; Garty BZ; Samra Z; Varsano I; Nitzan M J Pediatr; 1993 Nov; 123(5):817-21. PubMed ID: 8229498 [TBL] [Abstract][Full Text] [Related]
2. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study. Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535 [TBL] [Abstract][Full Text] [Related]
3. Ceftibuten and trimethoprim-sulfamethoxazole for treatment of Shigella and enteroinvasive Escherichia coli disease. Prado D; López E; Liu H; Devoto S; Woloj M; Contrini M; Murray BE; Gómez H; Cleary TG Pediatr Infect Dis J; 1992 Aug; 11(8):644-7. PubMed ID: 1523076 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of pivmecillinam and cotrimoxazole in acute shigellosis in children. Prado D; Liu H; Velasquez T; Cleary TG Scand J Infect Dis; 1993; 25(6):713-9. PubMed ID: 8052810 [TBL] [Abstract][Full Text] [Related]
5. Once daily cefixime compared with twice daily trimethoprim/sulfamethoxazole for treatment of urinary tract infection in infants and children. Dagan R; Einhorn M; Lang R; Pomeranz A; Wolach B; Miron D; Raz R; Weinstock A; Steinberger J Pediatr Infect Dis J; 1992 Mar; 11(3):198-203. PubMed ID: 1565534 [TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled, single-blind study comparing furazolidone with trimethoprim-sulfamethoxazole in the empirical treatment of acute invasive diarrhea. Rodriguez RS; Chavez AZ; Galindo E Scand J Gastroenterol Suppl; 1989; 169():47-53. PubMed ID: 2694343 [TBL] [Abstract][Full Text] [Related]
7. Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Gotuzzo E; Oberhelman RA; Maguiña C; Berry SJ; Yi A; Guzman M; Ruiz R; Leon-Barua R; Sack RB Antimicrob Agents Chemother; 1989 Jul; 33(7):1101-4. PubMed ID: 2675757 [TBL] [Abstract][Full Text] [Related]
8. Comparison of trimethoprim-sulfamethoxazole and ampicillin theraphy for shigellosis in ambulatory. Nelson JD; Kusmiesz H; Jackson LH J Pediatr; 1976 Sep; 89(3):491-3. PubMed ID: 1048183 [TBL] [Abstract][Full Text] [Related]
9. Antibiotic treatment of acute shigellosis: failure of cefamandole compared with trimethoprim/ sulfamethoxazole and ampicillin. Orenstein WA; Ross L; Overturf GD; Wilkins J; Redfield DR; Underman A Am J Med Sci; 1981; 282(1):27-33. PubMed ID: 7270569 [TBL] [Abstract][Full Text] [Related]
10. Treatment of shigellosis with cefixime: two days vs. five days. Martin JM; Pitetti R; Maffei F; Tritt J; Smail K; Wald ER Pediatr Infect Dis J; 2000 Jun; 19(6):522-6. PubMed ID: 10877166 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002. Sivapalasingam S; Nelson JM; Joyce K; Hoekstra M; Angulo FJ; Mintz ED Antimicrob Agents Chemother; 2006 Jan; 50(1):49-54. PubMed ID: 16377666 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children. Helvaci M; Bektaşlar D; Ozkaya B; Yaprak I; Umurtak B; Ertuğrul A Acta Paediatr Jpn; 1998 Apr; 40(2):131-4. PubMed ID: 9581302 [TBL] [Abstract][Full Text] [Related]
13. Short-course norfloxacin and trimethoprim-sulfamethoxazole treatment of shigellosis and salmonellosis in Egypt. Bassily S; Hyams KC; el-Masry NA; Farid Z; Cross E; Bourgeois AL; Ayad E; Hibbs RG Am J Trop Med Hyg; 1994 Aug; 51(2):219-23. PubMed ID: 8074256 [TBL] [Abstract][Full Text] [Related]
14. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults. Salam MA; Seas C; Khan WA; Bennish ML Ann Intern Med; 1995 Oct; 123(7):505-8. PubMed ID: 7661494 [TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole therapy for shigellosis. Nelson JD; Kusmiesz H; Jackson LH; Woodman E JAMA; 1976 Mar; 235(12):1239-43. PubMed ID: 765518 [TBL] [Abstract][Full Text] [Related]
16. Failure of cefotaxime therapy in a child with shigellosis. Hoffman JA; Kim KS Pediatr Infect Dis J; 1996 Feb; 15(2):175-6. PubMed ID: 8822296 [No Abstract] [Full Text] [Related]
17. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Ashkenazi S; May-Zahav M; Sulkes J; Zilberberg R; Samra Z Antimicrob Agents Chemother; 1995 Apr; 39(4):819-23. PubMed ID: 7785977 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of urinary tract infection in persons with recent spinal cord injury: a prospective, randomized, double-blind, placebo-controlled study of trimethoprim-sulfamethoxazole. Gribble MJ; Puterman ML Am J Med; 1993 Aug; 95(2):141-52. PubMed ID: 8356980 [TBL] [Abstract][Full Text] [Related]
19. [Shigella serotypes and drug resistance patterns of strains isolated in Etimesgut, Turkey, in 1987]. Korten V; Mert A; Ovünç K; Ceyhan M; Acar S; Ulaş T Mikrobiyol Bul; 1988 Apr; 22(2):89-94. PubMed ID: 3078794 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance of Shigellae isolated in Michigan. Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]